Company Profile

  1. You are here:    Home
  2. Search Databases
  3. Search Company Registry
  4. Company Profile

Vanquish Bio LLC
Profile last edited on: 11/21/23      CAGE: 8WFB8      UEI: QSENLNFXPEP8

Business Identifier: Innovative/novel anti-cancer therapy based on Extracellular Vesicles (EVs).
Year Founded
2019
First Award
2022
Latest Award
2022
Program Status
Active
Popularity Index

Edit Company Profile

Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.
  Explanation Edit

Location Information

195 Vista Oak Drive
Longwood, FL 32779
   (314) 977-9296
   N/A
   www.vanqbio.com
Location: Single
Congr. District: 07
County: Seminole

Public Profile

Management of Vanquish Bio describe what the firm is about as their developing novel treatments for cancer based on the firm's patent pending Exosomes, also known as Extracellular Vesicles (EVs), derived from novel Natural Killer (NK) cells

Extent of SBIR involvement

User Avatar
Phase I Awards
1
Phase II Awards
0
Conversion Rate
0.00%
Phase I Dollars
$399,580
Phase II Dollars
$0
Total Awarded
$399,580

Synopsis: Awardee Business Condition

Employee Range
1-4
Revenue Range
Less than .5M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
N/A

Awards Distribution by Agency

Most Recent SBIR Projects
Year Phase Agency Total Amount
2022 1 NIH $399,580
Project Title: Development of Natural Killer (NK) Cell Line-Derived Extracellular Vesicles as a New Treatment for Cancer

Key People / Management

  Bryan Allinson

  Jacki Kornbluth

Company News

There are no news available.